DSC 5266 - Willkommen bei oncoletter - Oncoletter,...

20

Transcript of DSC 5266 - Willkommen bei oncoletter - Oncoletter,...

Page 1: DSC 5266 - Willkommen bei oncoletter - Oncoletter, …web.oncoletter.ch/files/cto_layout/Kongressdateien/ASC… ·  · 2014-01-18Metastatic Gastric or Gastroesophageal Junction (GEJ)
Page 2: DSC 5266 - Willkommen bei oncoletter - Oncoletter, …web.oncoletter.ch/files/cto_layout/Kongressdateien/ASC… ·  · 2014-01-18Metastatic Gastric or Gastroesophageal Junction (GEJ)
Page 3: DSC 5266 - Willkommen bei oncoletter - Oncoletter, …web.oncoletter.ch/files/cto_layout/Kongressdateien/ASC… ·  · 2014-01-18Metastatic Gastric or Gastroesophageal Junction (GEJ)
Page 4: DSC 5266 - Willkommen bei oncoletter - Oncoletter, …web.oncoletter.ch/files/cto_layout/Kongressdateien/ASC… ·  · 2014-01-18Metastatic Gastric or Gastroesophageal Junction (GEJ)
Page 5: DSC 5266 - Willkommen bei oncoletter - Oncoletter, …web.oncoletter.ch/files/cto_layout/Kongressdateien/ASC… ·  · 2014-01-18Metastatic Gastric or Gastroesophageal Junction (GEJ)
Page 6: DSC 5266 - Willkommen bei oncoletter - Oncoletter, …web.oncoletter.ch/files/cto_layout/Kongressdateien/ASC… ·  · 2014-01-18Metastatic Gastric or Gastroesophageal Junction (GEJ)
Page 7: DSC 5266 - Willkommen bei oncoletter - Oncoletter, …web.oncoletter.ch/files/cto_layout/Kongressdateien/ASC… ·  · 2014-01-18Metastatic Gastric or Gastroesophageal Junction (GEJ)
Page 8: DSC 5266 - Willkommen bei oncoletter - Oncoletter, …web.oncoletter.ch/files/cto_layout/Kongressdateien/ASC… ·  · 2014-01-18Metastatic Gastric or Gastroesophageal Junction (GEJ)
Page 9: DSC 5266 - Willkommen bei oncoletter - Oncoletter, …web.oncoletter.ch/files/cto_layout/Kongressdateien/ASC… ·  · 2014-01-18Metastatic Gastric or Gastroesophageal Junction (GEJ)
Page 10: DSC 5266 - Willkommen bei oncoletter - Oncoletter, …web.oncoletter.ch/files/cto_layout/Kongressdateien/ASC… ·  · 2014-01-18Metastatic Gastric or Gastroesophageal Junction (GEJ)
Page 11: DSC 5266 - Willkommen bei oncoletter - Oncoletter, …web.oncoletter.ch/files/cto_layout/Kongressdateien/ASC… ·  · 2014-01-18Metastatic Gastric or Gastroesophageal Junction (GEJ)
Page 12: DSC 5266 - Willkommen bei oncoletter - Oncoletter, …web.oncoletter.ch/files/cto_layout/Kongressdateien/ASC… ·  · 2014-01-18Metastatic Gastric or Gastroesophageal Junction (GEJ)
Page 13: DSC 5266 - Willkommen bei oncoletter - Oncoletter, …web.oncoletter.ch/files/cto_layout/Kongressdateien/ASC… ·  · 2014-01-18Metastatic Gastric or Gastroesophageal Junction (GEJ)
Page 14: DSC 5266 - Willkommen bei oncoletter - Oncoletter, …web.oncoletter.ch/files/cto_layout/Kongressdateien/ASC… ·  · 2014-01-18Metastatic Gastric or Gastroesophageal Junction (GEJ)
Page 15: DSC 5266 - Willkommen bei oncoletter - Oncoletter, …web.oncoletter.ch/files/cto_layout/Kongressdateien/ASC… ·  · 2014-01-18Metastatic Gastric or Gastroesophageal Junction (GEJ)
Page 16: DSC 5266 - Willkommen bei oncoletter - Oncoletter, …web.oncoletter.ch/files/cto_layout/Kongressdateien/ASC… ·  · 2014-01-18Metastatic Gastric or Gastroesophageal Junction (GEJ)
Page 17: DSC 5266 - Willkommen bei oncoletter - Oncoletter, …web.oncoletter.ch/files/cto_layout/Kongressdateien/ASC… ·  · 2014-01-18Metastatic Gastric or Gastroesophageal Junction (GEJ)
Page 18: DSC 5266 - Willkommen bei oncoletter - Oncoletter, …web.oncoletter.ch/files/cto_layout/Kongressdateien/ASC… ·  · 2014-01-18Metastatic Gastric or Gastroesophageal Junction (GEJ)
Page 19: DSC 5266 - Willkommen bei oncoletter - Oncoletter, …web.oncoletter.ch/files/cto_layout/Kongressdateien/ASC… ·  · 2014-01-18Metastatic Gastric or Gastroesophageal Junction (GEJ)
Page 20: DSC 5266 - Willkommen bei oncoletter - Oncoletter, …web.oncoletter.ch/files/cto_layout/Kongressdateien/ASC… ·  · 2014-01-18Metastatic Gastric or Gastroesophageal Junction (GEJ)

OPERATING WEIGHT ENGINE OUTPUT SHOVEL CAPACITY …ar250.de/files/cto_layout/content/prospekt_ar250_en.pdf · STANDARD SHOVEL CAPACITY 13,800 2.4 160 FIRST IMPRESSIONS COUNT! We think

OPERATING WEIGHT ENGINE OUTPUT SHOVEL CAPACITY …ar250.de/files/cto_layout/content/prospekt_ar250_en.pdf · STANDARD SHOVEL CAPACITY 13,800 2.4 160 FIRST IMPRESSIONS COUNT! We think

SABCS 2018 - oncoletter€¦ · committee member for the IMpassion130 and KATE2 trials This study is sponsored by F. Hoffmann-La Roche, Ltd Editorial support, funded by the sponsor,

SABCS 2018 - oncoletter€¦ · committee member for the IMpassion130 and KATE2 trials This study is sponsored by F. Hoffmann-La Roche, Ltd Editorial support, funded by the sponsor,

LIGHTING ELECTRONICS - CIS Elektrotechnik GmbHcis-ship.com/files/cto_layout/downloads/teknoware.pdf · 2016-08-26 · 2 TEKNOWARE LIGHTING ELECTRONICS FOR DEMANDING APPLICATIONS Our

LIGHTING ELECTRONICS - CIS Elektrotechnik GmbHcis-ship.com/files/cto_layout/downloads/teknoware.pdf · 2016-08-26 · 2 TEKNOWARE LIGHTING ELECTRONICS FOR DEMANDING APPLICATIONS Our

SABCS 2018 - oncoletter · This presentation is the intellectual property of Contact for permission to repnnt and,'M distribute, ... Alpe isib e 10 12 14 16 18 Time (months) Endocrine

SABCS 2018 - oncoletter · This presentation is the intellectual property of Contact for permission to repnnt and,'M distribute, ... Alpe isib e 10 12 14 16 18 Time (months) Endocrine

SABCS 2013 - oncoletterweb.oncoletter.ch/.../Kongressdateien/SABCS2013/S3-06.pdf · 2013. 12. 13. · Dr. Schnitt: Nothing to disclose. 2013 SAN ANTONIO BREAST CANCER SYMPOSIUM .

SABCS 2013 - oncoletterweb.oncoletter.ch/.../Kongressdateien/SABCS2013/S3-06.pdf · 2013. 12. 13. · Dr. Schnitt: Nothing to disclose. 2013 SAN ANTONIO BREAST CANCER SYMPOSIUM .

Slide 2 / 20 - oncoletterweb.oncoletter.ch/files/cto_layout/Kongressdateien/SABCS2015/S5-07.… · NEGATIVE ADVANCED BREAST CANCER ENROLLED IN KEYNOTE-028 Speaker: Hope S Rugo Slide

Slide 2 / 20 - oncoletterweb.oncoletter.ch/files/cto_layout/Kongressdateien/SABCS2015/S5-07.… · NEGATIVE ADVANCED BREAST CANCER ENROLLED IN KEYNOTE-028 Speaker: Hope S Rugo Slide

SELECTED REFERENCES OF TRAFOTEK DELIVERIES SELECTED ...cis-ship.com/files/cto_layout/downloads/References 1 March 2016.pdf · SELECTED REFERENCES OF TRAFOTEK DELIVERIES SELECTED REFERENCES

SELECTED REFERENCES OF TRAFOTEK DELIVERIES SELECTED ...cis-ship.com/files/cto_layout/downloads/References 1 March 2016.pdf · SELECTED REFERENCES OF TRAFOTEK DELIVERIES SELECTED REFERENCES

web.oncoletter.chweb.oncoletter.ch/files/cto_layout/Kongressdateien/ASH2014/ASH2014_80.pdf · Tx to at least one prior regumen and then developed PO s 60 days corn*tTtg their last

web.oncoletter.chweb.oncoletter.ch/files/cto_layout/Kongressdateien/ASH2014/ASH2014_80.pdf · Tx to at least one prior regumen and then developed PO s 60 days corn*tTtg their last

oncoletterweb.oncoletter.ch/files/cto_layout/Kongressdateien/ASCO... · 2017. 1. 21. · PRODIGE OE RECHERC*e GEMOX vs surveillance following surgery of localized biliary tract cancer:

oncoletterweb.oncoletter.ch/files/cto_layout/Kongressdateien/ASCO... · 2017. 1. 21. · PRODIGE OE RECHERC*e GEMOX vs surveillance following surgery of localized biliary tract cancer:

SABCS 2016web.oncoletter.ch/files/cto_layout/Kongressdateien/SABCS2016/SLID… · Double-blind Concordance Study of Breast Cancer Recommendations Between Manipal Multidisc* Tumor

SABCS 2016web.oncoletter.ch/files/cto_layout/Kongressdateien/SABCS2016/SLID… · Double-blind Concordance Study of Breast Cancer Recommendations Between Manipal Multidisc* Tumor

oncoletterweb.oncoletter.ch/files/cto_layout/Kongressdateien/... · National reference labs Central sample collection Marker identification (IGH, t(11;14)) Sequencing and ASO Primer

oncoletterweb.oncoletter.ch/files/cto_layout/Kongressdateien/... · National reference labs Central sample collection Marker identification (IGH, t(11;14)) Sequencing and ASO Primer

SABCS 2013 - oncoletterweb.oncoletter.ch/files/cto_layout/Kongressdateien/... · 'One P30+DOC randomized patient received RAM DOC n Cycle I only therefore is included in the RAM DOC

SABCS 2013 - oncoletterweb.oncoletter.ch/files/cto_layout/Kongressdateien/... · 'One P30+DOC randomized patient received RAM DOC n Cycle I only therefore is included in the RAM DOC

Intramedullary Nailing Intramed System Interlocking System ...1.treu.com/portfolio-details/nails.html?file=files/cto_layout/download… · Intramedullary Nailing Intramed System Interlocking

Intramedullary Nailing Intramed System Interlocking System ...1.treu.com/portfolio-details/nails.html?file=files/cto_layout/download… · Intramedullary Nailing Intramed System Interlocking

Thema: Willensvollstreckung Referenten: Dr. Markus Pichler ...szlaw.ch/files/cto_layout/pdf_referate/referate... · Mietverträge, Inkasso, Instandhaltung der Liegenschaften, Wahrnehmung

Thema: Willensvollstreckung Referenten: Dr. Markus Pichler ...szlaw.ch/files/cto_layout/pdf_referate/referate... · Mietverträge, Inkasso, Instandhaltung der Liegenschaften, Wahrnehmung

oncoletter 2017/0… · Durvalumab + Tremelimumab vs Durvalumab vs Tremelimumab in I-ICC Arm + (n=36; 12 subjoctstviral status typo) ... ASCO 2016. Abstract 4012. 2017 Gastrointestinal

oncoletter 2017/0… · Durvalumab + Tremelimumab vs Durvalumab vs Tremelimumab in I-ICC Arm + (n=36; 12 subjoctstviral status typo) ... ASCO 2016. Abstract 4012. 2017 Gastrointestinal

oncoletterweb.oncoletter.ch/files/cto_layout/Kongressdateien/ASH... · 2015. 12. 8. · Randomized, double-blind, placebo-controlled study in adult ß-thalasserupatients (including

oncoletterweb.oncoletter.ch/files/cto_layout/Kongressdateien/ASH... · 2015. 12. 8. · Randomized, double-blind, placebo-controlled study in adult ß-thalasserupatients (including

Slide 2 / 17web.oncoletter.ch/files/cto_layout/Kongressdateien/SABCS2015/S5-0… · slide 9 / 17 slide 10 / 17 page 5. undefined s5-05 trastuzumab emtansine improves overall survival

Slide 2 / 17web.oncoletter.ch/files/cto_layout/Kongressdateien/SABCS2015/S5-0… · slide 9 / 17 slide 10 / 17 page 5. undefined s5-05 trastuzumab emtansine improves overall survival

web.oncoletter.chweb.oncoletter.ch/files/cto_layout/Kongressdateien/ASCO-GI 2017/C05... · Rapido trial, results awaited Locally advanced Rectal Cancer International randomized multicentre

web.oncoletter.chweb.oncoletter.ch/files/cto_layout/Kongressdateien/ASCO-GI 2017/C05... · Rapido trial, results awaited Locally advanced Rectal Cancer International randomized multicentre

Plaster Shears and Instruments - 1.treu.com1.treu.com/portfolio-details/plaster.html?file=files/cto_layout/downloads/10 - Plaster... · Säge lassen sich alle Gips- und Kunststoffverbände

Plaster Shears and Instruments - 1.treu.com1.treu.com/portfolio-details/plaster.html?file=files/cto_layout/downloads/10 - Plaster... · Säge lassen sich alle Gips- und Kunststoffverbände

SABCS 2019 - oncoletter · lcm (34%) O nodes tumor and/or pgR.ve (64%) pertuzumab ER.ve and/or (64%) ER-ve (36%) Placebo Placebo Pertuzumab Placebo Pertuzumab This presentation is

SABCS 2019 - oncoletter · lcm (34%) O nodes tumor and/or pgR.ve (64%) pertuzumab ER.ve and/or (64%) ER-ve (36%) Placebo Placebo Pertuzumab Placebo Pertuzumab This presentation is